Interleukin-5 Antagonist Monoclonal Antibody Therapy Improves Symptoms and Reduces Steroid Dependence in Eosinophilic Myocarditis Patients
Eosinophilic myocarditis (EM) is a rare disease associated with significant morbidity and mortality. This case series follows the clinical courses of 3 patients with EM. The use of mepolizumab, an anti–interleukin-5 monoclonal antibody, as an adjunctive treatment was associated with stabilization of cardiac function and improved long-term outcomes..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:29 |
|---|---|
| Enthalten in: |
JACC: Case Reports - 29(2024), 7, Seite 102267- |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Vincenzo Trovato, MD [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Diseases of the circulatory (Cardiovascular) system |
|---|
| doi: |
10.1016/j.jaccas.2024.102267 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ091684250 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ091684250 | ||
| 003 | DE-627 | ||
| 005 | 20240412101539.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240412s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jaccas.2024.102267 |2 doi | |
| 035 | |a (DE-627)DOAJ091684250 | ||
| 035 | |a (DE-599)DOAJf941ee0802df47ec93d6d9fd0db27371 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 050 | 0 | |a RC666-701 | |
| 100 | 0 | |a Vincenzo Trovato, MD |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Interleukin-5 Antagonist Monoclonal Antibody Therapy Improves Symptoms and Reduces Steroid Dependence in Eosinophilic Myocarditis Patients |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Eosinophilic myocarditis (EM) is a rare disease associated with significant morbidity and mortality. This case series follows the clinical courses of 3 patients with EM. The use of mepolizumab, an anti–interleukin-5 monoclonal antibody, as an adjunctive treatment was associated with stabilization of cardiac function and improved long-term outcomes. | ||
| 650 | 4 | |a eosinophilic myocarditis | |
| 650 | 4 | |a interleukin-5 | |
| 650 | 4 | |a myocarditis | |
| 650 | 4 | |a reduced ejection fraction | |
| 650 | 4 | |a steroid-sparing | |
| 653 | 0 | |a Diseases of the circulatory (Cardiovascular) system | |
| 700 | 0 | |a Ashlee Asada, MD |e verfasserin |4 aut | |
| 700 | 0 | |a Lynn Fussner, MD |e verfasserin |4 aut | |
| 700 | 0 | |a Casey Curtis, MD |e verfasserin |4 aut | |
| 700 | 0 | |a Rami Kahwash, MD |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t JACC: Case Reports |d Elsevier, 2021 |g 29(2024), 7, Seite 102267- |w (DE-627)DOAJ078609291 |x 26660849 |7 nnns |
| 773 | 1 | 8 | |g volume:29 |g year:2024 |g number:7 |g pages:102267- |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.jaccas.2024.102267 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/f941ee0802df47ec93d6d9fd0db27371 |z kostenfrei |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S2666084924000482 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2666-0849 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 29 |j 2024 |e 7 |h 102267- | ||